Loss-of-function mutation in inositol monophosphatase 1 (IMPA1) results in abnormal synchrony in resting-state EEG. 2019

Christopher P Walker, and Andre L S Pessoa, and Thalita Figueiredo, and Megan Rafferty, and Uirá S Melo, and Paulo R Nóbrega, and Nicholas Murphy, and Fernando Kok, and Mayana Zatz, and Silvana Santos, and Raymond Y Cho
Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA. christopher.p.walker@uth.tmc.edu.

Dysregulation of the inositol cycle is implicated in a wide variety of human diseases, including developmental defects and neurological diseases. A homozygous frameshift mutation in IMPA1, coding for the enzyme inositol monophosphatase 1 (IMPase), has recently been associated with severe intellectual disability (ID) in a geographically isolated consanguineous family in Northeastern Brazil (Figueredo et al., 2016). However, the neurophysiologic mechanisms that mediate the IMPA1 mutation and associated ID phenotype have not been characterized. To this end, resting EEG (eyes-open and eyes-closed) was collected from the Figueredo et al. pedigree. Quantitative EEG measures, including mean power, dominant frequency and dominant frequency variability, were investigated for allelic associations using multivariate family-based association test using generalized estimating equations. We found that the IMPA1 mutation was associated with relative decreases in frontal theta band power as well as altered alpha-band variability with no regional specificity during the eyes-open condition. For the eyes-closed condition, there was altered dominant theta frequency variability in the central and parietal regions. These findings represent the first human in vivo phenotypic assessment of brain function disturbances associated with a loss-of-function IMPA1 mutation, and thus an important first step towards an understanding the pathophysiologic mechanisms of intellectual disability associated with the mutation that affects this critical metabolic pathway.

UI MeSH Term Description Entries
D008297 Male Males
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D010744 Phosphoric Monoester Hydrolases A group of hydrolases which catalyze the hydrolysis of monophosphoric esters with the production of one mole of orthophosphate. Phosphatase,Phosphatases,Phosphohydrolase,Phosphohydrolases,Phosphomonoesterase,Phosphomonoesterases,Phosphoric Monoester Hydrolase,Hydrolase, Phosphoric Monoester,Hydrolases, Phosphoric Monoester,Monoester Hydrolase, Phosphoric
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Christopher P Walker, and Andre L S Pessoa, and Thalita Figueiredo, and Megan Rafferty, and Uirá S Melo, and Paulo R Nóbrega, and Nicholas Murphy, and Fernando Kok, and Mayana Zatz, and Silvana Santos, and Raymond Y Cho
August 2016, Molecular psychiatry,
Christopher P Walker, and Andre L S Pessoa, and Thalita Figueiredo, and Megan Rafferty, and Uirá S Melo, and Paulo R Nóbrega, and Nicholas Murphy, and Fernando Kok, and Mayana Zatz, and Silvana Santos, and Raymond Y Cho
July 2021, Molecular psychiatry,
Christopher P Walker, and Andre L S Pessoa, and Thalita Figueiredo, and Megan Rafferty, and Uirá S Melo, and Paulo R Nóbrega, and Nicholas Murphy, and Fernando Kok, and Mayana Zatz, and Silvana Santos, and Raymond Y Cho
October 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Christopher P Walker, and Andre L S Pessoa, and Thalita Figueiredo, and Megan Rafferty, and Uirá S Melo, and Paulo R Nóbrega, and Nicholas Murphy, and Fernando Kok, and Mayana Zatz, and Silvana Santos, and Raymond Y Cho
December 2012, Environmental microbiology reports,
Christopher P Walker, and Andre L S Pessoa, and Thalita Figueiredo, and Megan Rafferty, and Uirá S Melo, and Paulo R Nóbrega, and Nicholas Murphy, and Fernando Kok, and Mayana Zatz, and Silvana Santos, and Raymond Y Cho
January 2023, Cancer medicine,
Christopher P Walker, and Andre L S Pessoa, and Thalita Figueiredo, and Megan Rafferty, and Uirá S Melo, and Paulo R Nóbrega, and Nicholas Murphy, and Fernando Kok, and Mayana Zatz, and Silvana Santos, and Raymond Y Cho
January 2007, The Journal of biological chemistry,
Christopher P Walker, and Andre L S Pessoa, and Thalita Figueiredo, and Megan Rafferty, and Uirá S Melo, and Paulo R Nóbrega, and Nicholas Murphy, and Fernando Kok, and Mayana Zatz, and Silvana Santos, and Raymond Y Cho
November 2013, Infection and immunity,
Christopher P Walker, and Andre L S Pessoa, and Thalita Figueiredo, and Megan Rafferty, and Uirá S Melo, and Paulo R Nóbrega, and Nicholas Murphy, and Fernando Kok, and Mayana Zatz, and Silvana Santos, and Raymond Y Cho
March 2013, Journal of neurochemistry,
Christopher P Walker, and Andre L S Pessoa, and Thalita Figueiredo, and Megan Rafferty, and Uirá S Melo, and Paulo R Nóbrega, and Nicholas Murphy, and Fernando Kok, and Mayana Zatz, and Silvana Santos, and Raymond Y Cho
January 2018, NeuroImage. Clinical,
Christopher P Walker, and Andre L S Pessoa, and Thalita Figueiredo, and Megan Rafferty, and Uirá S Melo, and Paulo R Nóbrega, and Nicholas Murphy, and Fernando Kok, and Mayana Zatz, and Silvana Santos, and Raymond Y Cho
January 1999, Journal of enzyme inhibition,
Copied contents to your clipboard!